The mechanism underlying these effects in HPS might be partly occurring via Akt/NF-κB pathway inactivation, but not HIF-1α, and via attenuation of the VEGF-A/VEGFR-2 related angiogenesis pathway. The gene discussed is HIF1A; the disease is Hermansky-Pudlak syndrome.